 Cyclohexanols
"Cyclohexanols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Monohydroxy derivatives of cyclohexanes that contain the general formula R-C6H11O. They have a camphorlike odor and are used in making soaps, insecticides, germicides, dry cleaning, and plasticizers.
| Descriptor ID |
D003511
|
| MeSH Number(s) |
D02.033.415.510.500 D02.455.426.392.368.367.318 D10.289.510.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cyclohexanols".
Below are MeSH descriptors whose meaning is more specific than "Cyclohexanols".
This graph shows the total number of publications written about "Cyclohexanols" by people in this website by year, and whether "Cyclohexanols" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 1 | 0 | 1 | | 2007 | 0 | 1 | 1 | | 2012 | 1 | 0 | 1 | | 2014 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cyclohexanols" by people in Profiles.
-
VanderWeide LA, Smith SM, Trinkley KE. A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia. J Clin Pharm Ther. 2015 Feb; 40(1):1-6.
-
Newton KM, Carpenter JS, Guthrie KA, Anderson GL, Caan B, Cohen LS, Ensrud KE, Freeman EW, Joffe H, Sternfeld B, Reed SD, Sherman S, Sammel MD, Kroenke K, Larson JC, Lacroix AZ. Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause. 2014 Jan; 21(1):45-58.
-
Zhang W, McIver AL, Stashko MA, DeRyckere D, Branchford BR, Hunter D, Kireev D, Miley MJ, Norris-Drouin J, Stewart WM, Lee M, Sather S, Zhou Y, Di Paola JA, Machius M, Janzen WP, Earp HS, Graham DK, Frye SV, Wang X. Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis. J Med Chem. 2013 Dec 12; 56(23):9693-700.
-
Kwilasz AJ, Negus SS. Dissociable effects of the cannabinoid receptor agonists ?9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats. J Pharmacol Exp Ther. 2012 Nov; 343(2):389-400.
-
Robinson-Papp J, Simpson DM. Safety profile of treatment in diabetic peripheral neuropathic pain. Pain Med. 2007 Sep; 8 Suppl 2:S43-9.
-
Little JT, Ketter TA, Kimbrell TA, Dunn RT, Benson BE, Willis MW, Luckenbaugh DA, Post RM. Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biol Psychiatry. 2005 Feb 01; 57(3):220-8.
-
Steeghs M, Bais HP, de Gouw J, Goldan P, Kuster W, Northway M, Fall R, Vivanco JM. Proton-transfer-reaction mass spectrometry as a new tool for real time analysis of root-secreted volatile organic compounds in Arabidopsis. Plant Physiol. 2004 May; 135(1):47-58.
-
Silk KR, Yager J. Suggested guidelines for e-mail communication in psychiatric practice. J Clin Psychiatry. 2003 Jul; 64(7):799-806.
-
Linnebur SA, Saseen JJ, Pace WD. Venlafaxine-associated vaginal bleeding. Pharmacotherapy. 2002 May; 22(5):652-5.
-
Little JT, Ketter TA, Kimbrell TA, Danielson A, Benson B, Willis MW, Post RM. Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. Psychopharmacol Bull. 1996; 32(4):629-35.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|